Ipsen Developments Limited
Records under this name other than patents Ipsen Developments Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Ipsen Developments Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,125,804 | Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose Formerly held In force · High confidence | In force | High confidence | |
| US 11,534,394 | Pharmaceutical Composition Containing Botulinum Neurotoxin Formerly held Term ended Ended no later than Jun 27, 2026 · Medium confidence | Term ended | Ended no later than Jun 27, 2026 | Medium confidence |
| US 9,757,329 | Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose Term ended Term ended Jul 6, 2025 · High confidence | Term ended | Term ended Jul 6, 2025 | High confidence |
| US 10,561,604 | Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose Formerly held Term ended Term ended Jul 6, 2025 · High confidence | Term ended | Term ended Jul 6, 2025 | High confidence |
| US 8,337,862 | Method for Treating Knee Joint Pain Caused by Saphenous Nerve Entrapment Formerly held Lapsed on the fee record Ended Dec 25, 2024 · Medium confidence | Lapsed on the fee record | Ended Dec 25, 2024 | Medium confidence |
| US 8,277,822 | Botulinum Toxin Treatment Formerly held Lapsed on the fee record Ended Oct 2, 2024 · Medium confidence | Lapsed on the fee record | Ended Oct 2, 2024 | Medium confidence |
| US 7,838,009 | Use of Botulinum Toxin for the Preparation of a Medicament for the Treatment of Lithiasis of Salivary Gland, Gall Bladder, Kidney, or Pancreas Formerly held Lapsed on the fee record Ended Nov 23, 2022 · High confidence | Lapsed on the fee record | Ended Nov 23, 2022 | High confidence |
| US 8,877,456 | Quantification of Botulinum Toxin Formerly held Lapsed on the fee record Ended Nov 4, 2018 · High confidence | Lapsed on the fee record | Ended Nov 4, 2018 | High confidence |
| US 8,759,093 | Method for Determining the Selectivity of a Pre-Synaptic Neuromuscular Blocking Substance Formerly held Lapsed on the fee record Ended Jun 24, 2018 · Medium confidence | Lapsed on the fee record | Ended Jun 24, 2018 | Medium confidence |